US FDA Implementing Hybrid Work Policy In January
Agency employees will have on-site, telework and remote possibilities, but options will depend on the center, office and job duties.
You may also be interested in...
Ban On US FDA User Fee Spending For Certain Facility Costs Forced Budget Shift
Soon-to-be enacted limitation on user fees means building maintenance and other expenses must be paid with non-user fee dollars. The issue was thought to be a significant operational impediment, but the most recent appropriations bill provided some relief.
US FDA Opens OTP Director Search Again
The new job notice offers a top salary, but also invites questions about the candidate pool attracted by the original solicitation.
CBER’s New Home For Gene Therapies: OTAT Changes To OTP But Leadership Questions Remain
US FDA has not named permanent heads of several offices within the new Office of Therapeutic Products, the only super office in the Center for Biologics Evaluation and Research.